[{"address1": "Scheelev\u00e4gen 19", "city": "Lund", "zip": "223 70", "country": "Sweden", "phone": "46 4 62 86 53 70", "website": "https://www.bonesupport.com", "industry": "Medical Instruments & Supplies", "industryKey": "medical-instruments-supplies", "industryDisp": "Medical Instruments & Supplies", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also offers CERAMENT Bead Tray, an adjunctive local delivery option for surgeons for targeted delivery to osseous defects and for dead space management. In addition, the company develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, and foot and ankle surgery. The company was founded in 1999 and is headquartered in Lund, Sweden.", "fullTimeEmployees": 127, "companyOfficers": [{"maxAge": 1, "name": "Mr. Emil  Billb\u00e4ck", "age": 53, "title": "Chief Executive Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 9677000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. H\u00e5kan  Johansson", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 248000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael Wrang Mortensen", "age": 48, "title": "Executive Vice President of Global R&D and Operations", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Annelie Aava Vikner", "age": 52, "title": "Executive Vice President of Global Marketing", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Helena L. Brandt", "age": 58, "title": "Executive Vice President of Human Resources", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Diefenbeck M.D., Ph.D.", "age": 49, "title": "Executive VP of Medical & Clinical Affairs and Chief Medical Officer", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Fergus  MacLeod", "age": 53, "title": "GM & Executive VP of Commercial Operations of EUROW", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Roth", "age": 60, "title": "GM & Executive VP of Commercial Operations of North America", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Anna  Stegmark", "title": "Executive Vice President of Quality Management & Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 26.83, "open": 26.83, "dayLow": 26.83, "dayHigh": 26.83, "regularMarketPreviousClose": 26.83, "regularMarketOpen": 26.83, "regularMarketDayLow": 26.83, "regularMarketDayHigh": 26.83, "beta": 1.013, "trailingPE": 62.395348, "volume": 100, "regularMarketVolume": 100, "averageVolume": 1, "bid": 20.0, "ask": 36.3, "bidSize": 29200, "askSize": 21500, "marketCap": 1951131264, "fiftyTwoWeekLow": 5.88, "fiftyTwoWeekHigh": 26.83, "priceToSalesTrailing12Months": 2.6540189, "fiftyDayAverage": 26.034721, "twoHundredDayAverage": 20.14861, "currency": "USD", "enterpriseValue": 1664115712, "profitMargins": 0.39281, "floatShares": 57918775, "sharesOutstanding": 65787200, "heldPercentInsiders": 0.06667, "heldPercentInstitutions": 0.6348, "impliedSharesOutstanding": 72722000, "bookValue": 9.577, "priceToBook": 2.8015037, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "earningsQuarterlyGrowth": 4.266, "netIncomeToCommon": 288776992, "trailingEps": 0.43, "enterpriseToRevenue": 2.264, "enterpriseToEbitda": 21.584, "52WeekChange": 3.5629253, "SandP52WeekChange": 0.24014747, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "BOEUF", "underlyingSymbol": "BOEUF", "shortName": "Bonesupport Holding AB", "longName": "Bonesupport Holding AB (publ)", "firstTradeDateEpochUtc": 1594215000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "d21d33d9-e122-3855-857f-dc60327a2e99", "messageBoardId": "finmb_428236982", "gmtOffSetMilliseconds": -14400000, "currentPrice": 26.83, "recommendationKey": "none", "totalCash": 114577000, "totalCashPerShare": 1.743, "ebitda": 77100496, "totalDebt": 15393000, "quickRatio": 2.654, "currentRatio": 4.196, "totalRevenue": 735161024, "debtToEquity": 2.446, "revenuePerShare": 11.265, "returnOnAssets": 0.08299, "returnOnEquity": 0.63346, "freeCashflow": -49160752, "operatingCashflow": -20607000, "earningsGrowth": 4.125, "revenueGrowth": 0.566, "grossMargins": 0.92221, "ebitdaMargins": 0.10488, "operatingMargins": 0.13519, "financialCurrency": "SEK", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]